Cargando…
Recent Advances in treatment of urethral stricture disease in men
Urethral stricturing is a narrowing of the urethral lumen as a result of ischaemic spongiofibrosis. The main challenge of currently available treatment options is recurrence of the stricture. Recent advancements in the treatment of urethral strictures mainly came from the fields of regenerative medi...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202089/ https://www.ncbi.nlm.nih.gov/pubmed/32419925 http://dx.doi.org/10.12688/f1000research.21957.1 |
_version_ | 1783529668354244608 |
---|---|
author | Mangir, Naside Chapple, Christopher |
author_facet | Mangir, Naside Chapple, Christopher |
author_sort | Mangir, Naside |
collection | PubMed |
description | Urethral stricturing is a narrowing of the urethral lumen as a result of ischaemic spongiofibrosis. The main challenge of currently available treatment options is recurrence of the stricture. Recent advancements in the treatment of urethral strictures mainly came from the fields of regenerative medicine and tissue engineering. Research efforts have primarily focused on decreasing the recurrence of stricture after internal urethrotomy and constructing tissue-engineered urethral substitutes to improve clinical outcomes of urethroplasty surgeries. The aim of this article is to review the most recent advancements in the management of urethral stricture disease in men. |
format | Online Article Text |
id | pubmed-7202089 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | F1000 Research Limited |
record_format | MEDLINE/PubMed |
spelling | pubmed-72020892020-05-14 Recent Advances in treatment of urethral stricture disease in men Mangir, Naside Chapple, Christopher F1000Res Review Urethral stricturing is a narrowing of the urethral lumen as a result of ischaemic spongiofibrosis. The main challenge of currently available treatment options is recurrence of the stricture. Recent advancements in the treatment of urethral strictures mainly came from the fields of regenerative medicine and tissue engineering. Research efforts have primarily focused on decreasing the recurrence of stricture after internal urethrotomy and constructing tissue-engineered urethral substitutes to improve clinical outcomes of urethroplasty surgeries. The aim of this article is to review the most recent advancements in the management of urethral stricture disease in men. F1000 Research Limited 2020-05-05 /pmc/articles/PMC7202089/ /pubmed/32419925 http://dx.doi.org/10.12688/f1000research.21957.1 Text en Copyright: © 2020 Mangir N and Chapple C http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Mangir, Naside Chapple, Christopher Recent Advances in treatment of urethral stricture disease in men |
title | Recent Advances in treatment of urethral stricture disease in men |
title_full | Recent Advances in treatment of urethral stricture disease in men |
title_fullStr | Recent Advances in treatment of urethral stricture disease in men |
title_full_unstemmed | Recent Advances in treatment of urethral stricture disease in men |
title_short | Recent Advances in treatment of urethral stricture disease in men |
title_sort | recent advances in treatment of urethral stricture disease in men |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202089/ https://www.ncbi.nlm.nih.gov/pubmed/32419925 http://dx.doi.org/10.12688/f1000research.21957.1 |
work_keys_str_mv | AT mangirnaside recentadvancesintreatmentofurethralstricturediseaseinmen AT chapplechristopher recentadvancesintreatmentofurethralstricturediseaseinmen |